Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.

Leukemia research·2014

Same author

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.

Autophagy·2014

Same author

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Nature medicine·2014

Same author

Entosis, a key player in cancer cell competition.

Cell research·2014

Same author

Cytokines reinstate NK cell-mediated cancer immunosurveillance.

The Journal of clinical investigation·2014

Same author

Cell biology. Metabolic control of cell death.

Science (New York, N.Y.)·2014

Search research articles

Related Experiment Video

Updated: Sep 5, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cell transfer for cancer immunotherapy.

Liwei Zhao¹, Shuai Zhang¹, Oliver Kepp¹

¹Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.

International Review of Cell and Molecular Biology

|July 7, 2022

Summary

Dendritic cell (DC) immunotherapy shows promise for cancer treatment by enhancing immune responses. However, clinical efficacy is limited, necessitating strategies to optimize DC production, maturation, and checkpoint inhibition for improved cancer immunotherapy outcomes.

Keywords:

CRISPR Checkpoint blockade Gene editing Immunogenic cell death iniDC

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Experiment Videos

Last Updated: Sep 5, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Area of Science:

Immunology
Cancer Research
Immunotherapy

Background:

Dendritic cells (DCs) are crucial for cancer immunosurveillance, bridging innate and adaptive immunity.
Adoptive transfer of antigen-loaded DCs is a proposed immunotherapeutic strategy for cancer.
Current clinical efficacy of DC-based cancer immunotherapy remains limited despite preclinical success.

Purpose of the Study:

To review recent advancements in dendritic cell (DC) biology.
To explore actionable therapeutic strategies for improving DC-based cancer immunotherapies.
To discuss experimental and clinical approaches for enhancing DC immunotherapy efficacy.

Main Methods:

Literature review of recent findings in DC biology.
Analysis of experimental and clinical strategies for DC immunotherapy.
Focus on optimized DC production, antigen loading, maturation, and checkpoint inhibition.

Main Results:

DC-based immunotherapy holds significant potential for cancer treatment.
Several strategies are being investigated to overcome current limitations.
Optimizing DC function and overcoming inhibitory mechanisms are key.

Conclusions:

Improving DC production, antigen loading, and maturation are critical for efficacy.
Co-treatment with other immunotherapies and inhibiting DC checkpoints show promise.
Further research and clinical trials are needed to fully realize the potential of DC-based cancer immunotherapy.